A recent study showed that AZD1775, a Wee1 inhibitor targeting the cell cycle checkpoint, synergizes with the HDAC inhibitor Vorinostat to induce DNA damage and apoptosis in leukemia cells, including p53-wild type and deficient AML (Zhou et al., 2015). Here, HDAC9 is linked to acute myeloid leukemia.